meganpharmd.bsky.social
@meganpharmd.bsky.social
When I was a #pharmacy student, it felt like rotations flew by. As a preceptor, I swear they go even faster! I blinked and Block 5 was over. How?? I still have so much more wisdom to impart! Thank you @UHSPedu for the awesome learners! #PharmEd
November 14, 2025 at 3:51 PM
In Montana for @pgrnhub Scientific Meeting. Can’t wait for 3 days packed with solving challenges to clinical PGx implementation. Also, more beautiful morning hikes.
September 10, 2025 at 6:15 PM
No other professional meeting brings me as much joy as HOPA Annual Conference. So great to catch up with #OncoPharm friends in Portland last week.
April 14, 2025 at 7:30 PM
St Louis: please remember to vote today! And it’s not just mayor and comptroller - there are also elections for school board, community college trustees, and in a couple wards, alderperson too. www.stlouis-mo.gov/elections/in...
Elections
Election dates, sample ballots, results for the City of St. Louis.
www.stlouis-mo.gov
April 8, 2025 at 1:08 PM
So tempted to stand at my airplane gate bound for PDX and shout “Where’s my #OncoPharm crowd?!?” (I won’t, I don’t like to cause a scene. But I will be scrutinizing the lines carefully for familiar faces, or just people who look like fellow pharmacy nerds.) #HOPA2025
April 8, 2025 at 1:05 PM
Another great OncoPharm podcast episode out today. If you’re heading to #HOPA2025, do yourself a favor and download to listen on your travels. @bossaer.bsky.social has excellent recs for fun outside the conference! podcasts.apple.com/us/podcast/o...
Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview
Podcast Episode · OncoPharm · 04/08/2025 · 12m
podcasts.apple.com
April 8, 2025 at 12:59 PM
It seems to me that some of the best applications of AI in cancer are in identifying which patients can avoid unnecessary treatment. In this case, prostate cancer patients eligible for focal therapy instead of more aggressive interventions. Via @ascopost.bsky.social ascopost.com/news/march-2...
AI Tool May Help to Predict Which Patients With Prostate Cancer May Benefit From Focal Therapy
A novel artificial intelligence (AI) tool may help to determine which men with prostate cancer are most likely to benefit from partial gland cryoablation.
ascopost.com
March 24, 2025 at 9:53 PM
Reposted
I see the Arch! Happy 314 Day, St. Louis. Come play in Forest Park and visit our friends at the Art Museum, History Museum, Zoo, Science Center and more. SO many amenities make this an amazing and very St. Louis urban park.
March 14, 2025 at 8:22 PM
Reposted
Our cancer advocates are joining One Voice Against Cancer on Capitol Hill today to meet with lawmakers to discuss the critical need for increased funding for the NCI, NIH & CDC Cancer in the FY25 spending bill!

We can’t afford to pause progress on #CancerResearch & #CancerPrevention. #CancerVoice25
March 6, 2025 at 3:28 PM
Really pleased with the sourdough bagels I made this weekend
March 3, 2025 at 5:17 PM
Kudos @americanheart.bsky.social and Dr. Tochi Okwuosa on the new AI in cardio-oncology statement. Great read, I loved the emphasis on using tech to make cardioprotective monitoring & interventions more standardized and accessible for #cancer patients. www.ahajournals.org/doi/10.1161/...
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine
Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease an...
www.ahajournals.org
March 3, 2025 at 5:11 PM
Another molecular diagnostics partnerships announcement:
Myriad Genetics & PATHOMIQ . Cool to see these collaborations leveraging AI and precision medicine to improve clinical decision making. #cancer #CDSS www.globenewswire.com/news-release...
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
Myriad Genetics entered into a strategic collaboration with PATHOMIQ to exclusively license its AI technology platform for prostate cancer in the US....
www.globenewswire.com
February 24, 2025 at 9:36 PM
I'm excited about the partnership news re: Stemline & Tempus. It will enable notification of clinicians directly in their workflow when ESR1 testing is missing at disease progression. Hope this leads to more timely clinical decisions! #CDSS #mbcsm hitconsultant.net/2025/02/21/s...
Stemline Therapeutics to Deploy Tempus Next’s AI-Enabled Care Pathway Intelligence Platform
Tempus and Stemline announced a new collaboration to improve the use of ESR1 testing in metastatic breast cancer (mBC).
hitconsultant.net
February 24, 2025 at 7:08 PM
Great feature on the startup Reboot Rx. Love the work the team is doing to repurpose generic drugs for #cancer patients. We need more efforts like this focused on bringing down costs of care and expanding indications for safe medications. #oncopharm www.boston25news.com/news/local/i...
‘It’s a game changer’: Local scientist’s cancer research working to find easier way to save lives
A local scientist is using artificial intelligence to find new uses for existing drugs to hopefully save both lives and money.
www.boston25news.com
February 20, 2025 at 10:10 PM
Congrats to all the startups selected for the 2025 CancerX Accelerator cohort. Exciting to see so many innovative ideas that will impact patient and caregivers on the cancer care journey. www.businesswire.com/news/home/20... #cancerx
CancerX Launches 2025 Accelerator to Drive Innovation in Oncology
CancerX, a public-private partnership designed to accelerate innovation in the fight against cancer, announced today the launch of its 2025 Accelerato
www.businesswire.com
February 19, 2025 at 5:09 PM
Cool paper out of @UFPharmacy on integrating the Epic PGx module. It's going on the required reading list next time I take pharmacy students. pubmed.ncbi.nlm.nih.gov/39960348/
Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module - PubMed
In the past decade, pharmacogenomic (PGx) testing to predict drug response have emerged into clinical care. Clinical decision support (CDS) has and continues to play a key role in educating prescriber...
pubmed.ncbi.nlm.nih.gov
February 18, 2025 at 7:28 PM
Reposted
The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. Read our statement: https://buff.ly/4gRXNB8
February 18, 2025 at 6:09 PM
Hello Bluesky. I've been wanting to get more "social" again, and hoping to start fresh with a more scientifically-minded platform. I'll probably be dual-posting here and that other site, but we'll see how it goes for a while. Looking forward to talking about #cancer, #pharmacy, and maybe #sourdough.
February 18, 2025 at 7:20 PM